Shelly Stein Peller, PT | |
1825 Martha Berry Blvd Nw, Rome, GA 30165-1625 | |
(762) 235-2700 | |
(706) 236-6437 |
Full Name | Shelly Stein Peller |
---|---|
Gender | Female |
Speciality | Physical Therapy |
Experience | 44 Years |
Location | 1825 Martha Berry Blvd Nw, Rome, Georgia |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1124029780 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225100000X | Physical Therapist | PT001302 (Georgia) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Harbin Clinic Llc | 0446154231 | 264 |
News Archive
A study released today concluded that employers and younger people would end up paying more for their health insurance if Medicare's eligibility age were raised. However, the age change would also result in billions of dollars in taxpayer savings.
Aeterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrine therapy, today announced that it has received positive Scientific Advice from the European Medicines Agency (EMA) regarding the Phase 3 trial initiated last April for the development of its lead anticancer proprietary compound, perifosine, in refractory advanced colorectal cancer.
Royal Philips Electronics and RXi Pharmaceuticals Corporation, a US-based biopharmaceutical company, today announced that they have entered into a joint research agreement to explore the benefits of combining proprietary technologies from both companies for the targeted delivery of experimental therapeutics based on RNA interference.
TARIS Biomedical, a specialty pharmaceutical company developing innovative, targeted therapies to treat bladder diseases with high unmet medical need, announced today that it has dosed the first patient in its second Phase 2 clinical study with LiRIS, its novel product candidate, in patients with Interstitial Cystitis.
› Verified 4 days ago
Provider Name | Harbin Clinic Llc |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1679599088 PECOS PAC ID: 0446154231 Enrollment ID: O20031124000117 |
News Archive
A study released today concluded that employers and younger people would end up paying more for their health insurance if Medicare's eligibility age were raised. However, the age change would also result in billions of dollars in taxpayer savings.
Aeterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrine therapy, today announced that it has received positive Scientific Advice from the European Medicines Agency (EMA) regarding the Phase 3 trial initiated last April for the development of its lead anticancer proprietary compound, perifosine, in refractory advanced colorectal cancer.
Royal Philips Electronics and RXi Pharmaceuticals Corporation, a US-based biopharmaceutical company, today announced that they have entered into a joint research agreement to explore the benefits of combining proprietary technologies from both companies for the targeted delivery of experimental therapeutics based on RNA interference.
TARIS Biomedical, a specialty pharmaceutical company developing innovative, targeted therapies to treat bladder diseases with high unmet medical need, announced today that it has dosed the first patient in its second Phase 2 clinical study with LiRIS, its novel product candidate, in patients with Interstitial Cystitis.
› Verified 4 days ago
Provider Name | Independent Physical Therapy Of Georgia Llc |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1780636068 PECOS PAC ID: 2961312244 Enrollment ID: O20040303000396 |
News Archive
A study released today concluded that employers and younger people would end up paying more for their health insurance if Medicare's eligibility age were raised. However, the age change would also result in billions of dollars in taxpayer savings.
Aeterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrine therapy, today announced that it has received positive Scientific Advice from the European Medicines Agency (EMA) regarding the Phase 3 trial initiated last April for the development of its lead anticancer proprietary compound, perifosine, in refractory advanced colorectal cancer.
Royal Philips Electronics and RXi Pharmaceuticals Corporation, a US-based biopharmaceutical company, today announced that they have entered into a joint research agreement to explore the benefits of combining proprietary technologies from both companies for the targeted delivery of experimental therapeutics based on RNA interference.
TARIS Biomedical, a specialty pharmaceutical company developing innovative, targeted therapies to treat bladder diseases with high unmet medical need, announced today that it has dosed the first patient in its second Phase 2 clinical study with LiRIS, its novel product candidate, in patients with Interstitial Cystitis.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Shelly Stein Peller, PT 221 Technology Pkwy Nw, Rome, GA 30165-1369 Ph: (762) 235-1038 | Shelly Stein Peller, PT 1825 Martha Berry Blvd Nw, Rome, GA 30165-1625 Ph: (762) 235-2700 |
News Archive
A study released today concluded that employers and younger people would end up paying more for their health insurance if Medicare's eligibility age were raised. However, the age change would also result in billions of dollars in taxpayer savings.
Aeterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrine therapy, today announced that it has received positive Scientific Advice from the European Medicines Agency (EMA) regarding the Phase 3 trial initiated last April for the development of its lead anticancer proprietary compound, perifosine, in refractory advanced colorectal cancer.
Royal Philips Electronics and RXi Pharmaceuticals Corporation, a US-based biopharmaceutical company, today announced that they have entered into a joint research agreement to explore the benefits of combining proprietary technologies from both companies for the targeted delivery of experimental therapeutics based on RNA interference.
TARIS Biomedical, a specialty pharmaceutical company developing innovative, targeted therapies to treat bladder diseases with high unmet medical need, announced today that it has dosed the first patient in its second Phase 2 clinical study with LiRIS, its novel product candidate, in patients with Interstitial Cystitis.
› Verified 4 days ago
Marius Florin Bodiu, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 201 Turner Mccall Blvd Nw, Rome, GA 30165 Phone: 706-235-2727 Fax: 706-235-2726 | |
Buffy D Crenshaw, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 201 Turner Mccall Blvd Nw, Rome, GA 30165 Phone: 706-236-2758 Fax: 706-802-1408 | |
Mr. Steven John Wright, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3870 Martha Berry Hwy Ne, Rome, GA 30165 Phone: 706-378-3124 | |
Kimberly H Reynolds, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 304 E 6th Ave, Rome, GA 30161 Phone: 706-378-9044 Fax: 706-378-9046 | |
Erin Green Pollock, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 224 Shorter Ave Nw, Rome, GA 30165 Phone: 706-235-2727 Fax: 706-235-2726 | |
Ryan Blake Cheeley, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 201 Turner Mccall Blvd Nw, Rome, GA 30165 Phone: 706-236-2758 Fax: 706-802-1408 | |
Cory R Tucker, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 305 N 5th Ave Sw, Rome, GA 30165 Phone: 706-292-0040 Fax: 706-378-0556 |